Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37883725)

  • 1. Radiotherapy for Brain Metastases Near the End of Life: Characterizing Patients and Tumor Features.
    Silva SB; Barreto RB; de Oliveira FCG; Martin GSD; Takiguchi OMY; Chirichela IA; Miranda MHF; Bodnar D; Alves Reis LA; Pereira GCB; Miranda IL; Pereira BR; Arruda GV; Peria FM
    JCO Glob Oncol; 2023 Sep; 9():e2300143. PubMed ID: 37883725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
    Partl R; Richtig E; Avian A; Berghold A; Kapp KS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.
    Heisterkamp C; Haatanen T; Schild SE; Rades D
    Strahlenther Onkol; 2010 Feb; 186(2):70-75. PubMed ID: 20127223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
    Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?
    Nieder C; Nestle U; Motaref B; Walter K; Niewald M; Schnabel K
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):297-302. PubMed ID: 10661335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Dziggel L; Gebauer N; Bartscht T; Schild SE; Rades D
    Anticancer Res; 2018 Apr; 38(4):2391-2394. PubMed ID: 29599366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.
    Murray KJ; Scott C; Zachariah B; Michalski JM; Demas W; Vora NL; Whitton A; Movsas B
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):59-64. PubMed ID: 10924972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.
    Bernhardt D; Bozorgmehr F; Adeberg S; Opfermann N; von Eiff D; Rieber J; Kappes J; Foerster R; König L; Thomas M; Debus J; Steins M; Rieken S
    Lung Cancer; 2016 Nov; 101():76-81. PubMed ID: 27794411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.
    Rades D; Hansen HC; Schild SE; Janssen S
    Lung; 2019 Jun; 197(3):321-326. PubMed ID: 30927058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer - a retrospective analysis.
    Bartsch R; Fromm S; Rudas M; Wenzel C; Harbauer S; Roessler K; Kitz K; Steger GG; Weitmann HD; Poetter R; Zielinski CC; Dieckmann K
    Radiother Oncol; 2006 Sep; 80(3):313-7. PubMed ID: 16959347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors affecting the outcome of brain metastases from breast cancer.
    Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
    Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.
    Komosinska K; Kepka L; Niwinska A; Pietrzak L; Wierzchowski M; Tyc-Szczepaniak D; Kaczmarczyk A; Bujko K
    Acta Oncol; 2010 Apr; 49(3):382-8. PubMed ID: 20397770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
    Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
    Anticancer Res; 2018 May; 38(5):3111-3114. PubMed ID: 29715148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for patients with microsurgically resected brain metastases.
    Korinth MC; Delonge C; Hütter BO; Gilsbach JM
    Onkologie; 2002 Oct; 25(5):420-5. PubMed ID: 12415195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.
    Feyer P; Sautter-Bihl ML; Budach W; Dunst J; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R
    Strahlenther Onkol; 2010 Feb; 186(2):63-69. PubMed ID: 20127222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.